Genprex, Inc.
- GNPX
- NASDAQ
- Biotechnology
- Gene Therapy (Cancer/Diabetes)
$2.11
Today −7.86%Quote Oct 16, 2026, 08:00 PM UTC
−39.02%over the last month
Max drawdown −43.7%From 1-month high −43.7%3 months −70.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$1.7M
Quote Oct 16
Next earnings
Dec 2
Expected, not confirmed
Latest analyst target
—
Data unavailable
Floor
—
Data unavailable
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about GNPXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
13